United States Patent and Trademark Office issued a patent (#11,351,152) to the India Globalization Capital, Inc. (AMEX:IGC) titled “Method and Composition for Treating Seizure Disorders.”
The patent is assigned to IGC and relates to compositions and methods for treating multiple types of seizure disorders and epilepsy in humans and animals, using a combination of the cannabinoid CBD with other compounds. Subject to further research and study, the combination is intended to reduce side effects caused by hydantoin anticonvulsant drugs such as phenobarbital, by reducing the dosing of anticonvulsant drugs in humans, dogs, and cats.
